[
  {
    "ts": null,
    "headline": "Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q3 2025 Update",
    "summary": "Read here for an analysis of Cantillon Capital's Q3 2025 13F portfolio's key holdings, strategic moves in Broadcom, Adobe and Liberty Media.",
    "url": "https://finnhub.io/api/news?id=1c114ded76665816ec1a25dea94abe09c32e8aa024ce5f03b086d2fb540326cd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761858698,
      "headline": "Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q3 2025 Update",
      "id": 137273132,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Read here for an analysis of Cantillon Capital's Q3 2025 13F portfolio's key holdings, strategic moves in Broadcom, Adobe and Liberty Media.",
      "url": "https://finnhub.io/api/news?id=1c114ded76665816ec1a25dea94abe09c32e8aa024ce5f03b086d2fb540326cd"
    }
  },
  {
    "ts": null,
    "headline": "Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting",
    "summary": "Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher ScientificLOUISVILLE, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces its Corporate and Scientific presentations, and exhibitor presence at the 2025 AMP Annual Meeting, November 12-15, in Boston, MA. BIODESIX WORKSHOP: On November 12, at 4:00 ET, Dr. Gar",
    "url": "https://finnhub.io/api/news?id=1fdb70e610fc2da2c8f24714dca8e8dede70ec4e748d7f8710949c521b3e51d5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761819420,
      "headline": "Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting",
      "id": 137266616,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher ScientificLOUISVILLE, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces its Corporate and Scientific presentations, and exhibitor presence at the 2025 AMP Annual Meeting, November 12-15, in Boston, MA. BIODESIX WORKSHOP: On November 12, at 4:00 ET, Dr. Gar",
      "url": "https://finnhub.io/api/news?id=1fdb70e610fc2da2c8f24714dca8e8dede70ec4e748d7f8710949c521b3e51d5"
    }
  },
  {
    "ts": null,
    "headline": "Argus Research Maintains Thermo Fisher Scientific (TMO) Buy Recommendation",
    "summary": "Argus Research Maintains Thermo Fisher Scientific (TMO) Buy Recommendation",
    "url": "https://finnhub.io/api/news?id=4869f73f1b5a30b0ff81cbad8134c66d7aee3362a14fd2d1985c1f32b259ec1b",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761782886,
      "headline": "Argus Research Maintains Thermo Fisher Scientific (TMO) Buy Recommendation",
      "id": 137261673,
      "image": "",
      "related": "TMO",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=4869f73f1b5a30b0ff81cbad8134c66d7aee3362a14fd2d1985c1f32b259ec1b"
    }
  }
]